DNA — analysis and forecast
🧬 Faro multibagger DNA
Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.
Strongest: Room to grow and Business quality. Most lacking: Cash it generates and Sales engine.
Worth $657 M. To grow ×10 it would have to reach $6.6 B.
Sales -6% last quarter (year over year) and -25% last fiscal year · accelerating.
Gross margin 70%, operating margin -202%, return on equity -58%.
Free cash flow −$89 M a year = -13.5% of its value (burning cash).
Trades at 5.0× sales with no growth to back it.
Net debt equal to 17% of its value.
No recent federal contracts on the radar · inside a Faro megatrend · insiders own 4.7%.
⏱️ Timing (not scored): mid-range over 12 months (37%) · above its 200-day average · beating the S&P 500 by 15 points over 12 months.
Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →
🔢 What the numbers say
The last 12 months, in plain words
- Over the last year DNA is up 19.8%. Over about two years: +20.8%.
- Today it sits 32.3% below its 52-week high ($14.98) and +84.9% above the low ($5.48).
- The worst drop from a peak in those 12 months was 48.8%. Anyone who bought at the top had to sit through that.
- It rose on 48% of days. Best day: +21.4%. Worst day: -30.5%.
- Annual volatility around 122%: in a normal year a ±122% move would not be unusual for this stock (the S&P 500 usually runs 15–20%).
🗓️ Forecast by horizon
Directional bias · probability of rising · expected price and likely range (68%)
| Horizon | Bias | Prob. up | Expected price | 68% range |
|---|---|---|---|---|
| 1 day | Neutral | 46% | $10.14 +0.0% | $9.39 – $10.95 |
| 3 days | Neutral | 46% | $10.15 +0.1% | $8.88 – $11.60 |
| 1 week | Neutral | 47% | $10.15 +0.2% | $8.55 – $12.06 |
| 15 days | Neutral | 48% | $10.17 +0.4% | $7.97 – $12.98 |
| 1 month | Neutral | 49% | $10.22 +0.8% | $7.18 – $14.54 |
| 3 months | Bullish | 49% | $10.38 +2.4% | $5.63 – $19.14 |
Recent momentum: -13.8% over 20 days · +31.5% over 60 days. The further out the horizon, the wider and more uncertain the forecast.
📈 Probability cone
📜 Government contracts
We have no notable federal contract on file for DNA. You can look it up yourself at USASpending.gov or in the Government Sources hub.
📚 Go deeper: Faro Library reports
PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 34 for $25 — included in Navigator and Admiral.
The market's memory: 100 years of crashes and recoveriesSince 1927 the S&P 500 has fallen more than 20% about a dozen times. It always recovered, but sometimes it took 25 y…6 pp. · Free preview →
Study: What the big winners had in commonMicron 13x, Carpenter 12x, NVIDIA 9x… We analyze the stocks that rose most in five years within the Faro universe: which…6 pp. · Free preview →
Practical guide: How to read an earnings report in 15 minutesEvery three months companies publish their numbers. The market reacts in seconds. A 7-step method, with real 2026 exampl…6 pp. · Free preview →❓ Frequently asked questions about DNA
Could DNA be the next NVIDIA?
Its Faro multibagger DNA is 43/100 (weak): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.
How much has DNA gone up in the last year?
Ginkgo Bioworks (DNA) is up 19.8% over the last 12 months and trades at $10.14, 32.3% below its 52-week high ($14.98). 52-week range: $5.48 – $14.98.
How volatile is DNA stock?
Its annualized volatility is around 122% and its worst drop from a peak over the last year was 48.8%. For reference, the S&P 500 usually moves 15–20% a year.
Does DNA have U.S. government contracts?
There is no notable federal contract in Faro's register. You can search USASpending.gov.
Is now a good time to buy DNA?
Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: neutral technical bias, RSI 50, price below its 50-day average and an estimated 49% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.
🧠 How it is calculated
The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.
🔦 Keep analyzing
Other stocks Faro watches